<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a <z:hpo ids='HP_0011010'>chronic</z:hpo>, relapsing, <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> of unknown origin </plain></SENT>
<SENT sid="1" pm="."><plain>The association of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is rare, and recent reports have indicated that <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> alone are not sufficient to control <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease associated with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and many patients die of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or <z:mp ids='MP_0001914'>hemorrhage</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>We report a case of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> with intestinal <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
<SENT sid="3" pm="."><plain>We performed cord blood transplantation with a myeloablative regimen as the primary treatment </plain></SENT>
<SENT sid="4" pm="."><plain>The patient achieved complete remission for both diseases, which continued for more than 16 months </plain></SENT>
<SENT sid="5" pm="."><plain>Our experience suggests that CBT may provide a potent therapeutic option for the treatment of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>-related <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease </plain></SENT>
</text></document>